NBSE
NeuBase Therapeutics Inc
Halal Rating :
Last Price
$0.37
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
NeuBase Therapeutics, Inc. is a biotechnology company focused on developing precision genetic medicines. The company specializes in developing therapies for genetic diseases using their proprietary peptide-nucleic acid antisense oligonucleotide (PATrOL™) platform technology. Their approach aims to address rare genetic diseases and common genetic disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate NeuBase Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.